SurModics Inc. +$0.72 $11.65
A Rodman & Renshaw analyst upgraded the shares to "market perform," saying the share price already reflects the risks the medical technology company is facing. (Ticker: SRDX)
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
Disney to cut 7,000 jobs in Iger's company 'transformation'
The Walt Disney Co. will cut about 7,000 jobs as part of an ambitious companywide cost-savings plan and "strategic reorganization" announced Wednesday by CEO Bob Iger.
Business
Abbott to buy New Brighton-based Cardiovascular Systems Inc. for $890 million
The acquisition allows Illinois-based medtech giant Abbott to expand its reach in treating arterial disease.
Business
Residents can return after air deemed safe from derailment
Evacuated residents can return to the Ohio village where crews burned toxic chemicals after a train derailed five days ago near the Pennsylvania state line now that monitors show no dangerous levels in the air, authorities said Wednesday.
Business
Driver in strange Tesla crash apparently moved to rear seat
Investigators from the National Transportation Safety Board apparently have solved the mystery of why no one was found behind the steering wheel of a Tesla that crashed in a Texas two years ago, killing two men.
Business
Minneapolis-based software firm Qumu bought by Canadian company
With the $18 million purchase, Qumu is no longer traded on the Nasdaq exchange.
